{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T15:38:56Z","timestamp":1792942736278,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.actbio.2025.01.019","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:21:03Z","timestamp":1736612463000},"page":"323-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Microenvironment-induced programmable nanotherapeutics restore mitochondrial dysfunction for the amelioration of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"194","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.actbio.2025.01.019_bib0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.019_bib0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.actbio.2025.01.019_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114991","article-title":"The great potential of flavonoids as candidate drugs for NAFLD","volume":"164","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.019_bib0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"issue":"15","key":"10.1016\/j.actbio.2025.01.019_bib0005","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/bph.15083","article-title":"Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice","volume":"177","author":"Li","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.019_bib0006","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jhep.2014.01.001","article-title":"Failing FXR expression in the liver links aging to hepatic steatosis","volume":"60","author":"Lefebvre","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.019_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.29788","article-title":"Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis","volume":"68","author":"Wang","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.actbio.2025.01.019_bib0008","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmet.2018.08.001","article-title":"Short-term mitochondrial permeability transition pore opening modulates histone lysine methylation at the early phase of somatic cell reprogramming","volume":"28","author":"Ying","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.019_bib0009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.30507","article-title":"Deficiency of mitochondrial glycerol 3-phosphate dehydrogenase contributes to hepatic steatosis","volume":"70","author":"Zheng","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.019_bib0010","doi-asserted-by":"crossref","first-page":"el2450","DOI":"10.1111\/jpi.12450","article-title":"Effects of melatonin on fatty liver disease: The role of NR4A1\/DNA-PKcs\/p53 pathway, mitochondrial fission, and mitophagy","volume":"64","author":"Zhou","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.actbio.2025.01.019_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.144952","article-title":"A reactive oxygen\/nitrogen species-eliminating natural product-based nanomedicine for prevention and treatment of inflammatory liver injury","volume":"472","author":"Zheng","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2025.01.019_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122291","article-title":"Long-term and liver-selected ginsenoside C-K nanoparticles retard NAFLD progression by restoring lipid homeostasis","volume":"301","author":"Yue","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.01.019_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.140585","article-title":"Multicomponent microspheres with spatiotemporal drug release for post-surgical liver cancer treatment and liver regeneration","volume":"455","author":"Zhong","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2025.01.019_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122232","article-title":"Dually fibronectin\/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis","volume":"301","author":"Li","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.01.019_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-0716-1433-4_12","article-title":"Protocols for mitochondria as the target of pharmacological therapy in the context of nonalcoholic fatty liver disease (NAFLD)","volume":"2310","author":"Grattagliano","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.actbio.2025.01.019_bib0016","article-title":"Recent advances in chemical biology of mitochondria targeting","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Chem"},{"issue":"33","key":"10.1016\/j.actbio.2025.01.019_bib0017","doi-asserted-by":"crossref","first-page":"27563","DOI":"10.1021\/acsami.7b09693","article-title":"Charge-reversible multifunctional HPMA copolymers for mitochondrial targeting","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2025.01.019_bib0018","doi-asserted-by":"crossref","first-page":"29257","DOI":"10.1021\/acsami.1c03196","article-title":"Reversing chemotherapy resistance by a synergy between lysosomal pH-activated mitochondrial drug delivery and erlotinib-mediated drug efflux inhibition","author":"Cheng","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"27","key":"10.1016\/j.actbio.2025.01.019_bib0019","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/adma.201201498","article-title":"Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery","volume":"24","author":"Mo","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2025.01.019_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304263","article-title":"Multivalent targeting of the asialoglycoprotein receptor by virus-like particles","author":"Hincapie","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.actbio.2025.01.019_bib0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biomaterials.2015.02.001","article-title":"Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery","volume":"52","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.actbio.2025.01.019_bib0022","article-title":"DNA-damage-response-targeting mitochondria-activated multifunctional prodrug strategy for self-defensive tumor therapy","volume":"61","author":"Jangili","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"issue":"62","key":"10.1016\/j.actbio.2025.01.019_bib0023","first-page":"8790","article-title":"pH-Responsive de-PEGylated nanoparticles based on triphenylphosphine\u2013quercetin self-assemblies for mitochondria-targeted cancer therapy","volume":"53","author":"Xing","year":"2017","journal-title":"ChemComm"},{"issue":"7","key":"10.1016\/j.actbio.2025.01.019_bib0024","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1021\/acs.biomac.1c00231","article-title":"Glycosylated nanotherapeutics with beta-lactamase reversible competitive inhibitory activity reinvigorates antibiotics against gram-negative bacteria","volume":"22","author":"Sun","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2025.01.019_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2019.09.016","article-title":"Predicting drug release kinetics from nanocarriers inside dialysis bags","volume":"315","author":"Yu","year":"2019","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2025.01.019_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121656","article-title":"An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury","volume":"287","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.actbio.2025.01.019_bib0027","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2025.01.019_bib0028","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/07388551.2014.930017","article-title":"Liver cell-targeted delivery of therapeutic molecules","volume":"36","author":"Kang","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"issue":"2","key":"10.1016\/j.actbio.2025.01.019_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCRESAHA.119.316306","article-title":"Role of Mitochondrial calcium and the permeability transition pore in regulating cell death","volume":"126","author":"Bauer","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.actbio.2025.01.019_bib0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat. Rev. Endocrinol"},{"issue":"44","key":"10.1016\/j.actbio.2025.01.019_bib0031","doi-asserted-by":"crossref","first-page":"13080","DOI":"10.1021\/acs.jafc.1c05213","article-title":"Erythritol improves nonalcoholic fatty liver disease by activating Nrf2 antioxidant capacity","volume":"69","author":"Jin","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.actbio.2025.01.019_bib0032","first-page":"126","article-title":"ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance, Free Radic","volume":"199","author":"Wang","year":"2023","journal-title":"Biol. Med"},{"issue":"1","key":"10.1016\/j.actbio.2025.01.019_bib0033","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1038\/s41598-023-34710-x","article-title":"Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosis","volume":"13","author":"Undamatla","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.actbio.2025.01.019_bib0034","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1535370213489446","article-title":"Role of p62\/SQSTM1 in liver physiology and pathogenesis","volume":"238","author":"Manley","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"3","key":"10.1016\/j.actbio.2025.01.019_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.15252\/embr.201643309","article-title":"Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy","volume":"18","author":"Chen","year":"2017","journal-title":"EMBO Rep"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T03:09:47Z","timestamp":1740625787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S1742706125000273"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.019","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microenvironment-induced programmable nanotherapeutics restore mitochondrial dysfunction for the amelioration of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}